NOS2 and cancer: Inducible nitric oxide synthase (iNOS) is a pro-tumorigenic enzyme that is highly upregulated in several cancers and is known to encourage tumor growth by promoting the activation of immunosuppressive tumor-infiltrating myeloid-derived suppressor cells (MDSCs) [32–34].